Human TNFRSF4/OX40 (Tumor necrosis factor receptor superfamily member 4) ELISA Kit

Este producto es parte de TNFRSF4 - TNF receptor superfamily member 4
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human TNFRSF4/OX40 (Tumor necrosis factor receptor superfamily member 4) ELISA Kit
category
ELISA Kits
provider
FineTest
reference
EH0310
tested applications
ELISA

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
ELISA Kits
Reactivity
Human
Detection Method
Colorimetric
Assay Data
4 hours
Assay Type
Sandwich ELISA, Double Antibody
Test Range
7.8-500pg/ml
Sensitivity
4.688pg/ml
Size 1
96T
Tested Applications
ELISA
Sample Type
Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Availability
Shipped within 10-14 working days.
Storage
2-8 °C for 12 months
UniProt ID
P43489
Alias
OX40,ACT35,CD134,IMD16,TXGP1L,OX40L receptor,TAX transcriptionally-activated glycoprotein 1 receptor
Background
Elisa kits for TNFRSF4
Status
RUO

TNFRSF4, commonly known as OX40 (CD134), is a member of the tumor necrosis factor receptor (TNFR) superfamily. It is an important costimulatory molecule expressed on T cells, specifically induced upon T cell activation. TNFRSF4 is known for its involvement in regulating immune responses, especially in T-cell proliferation, survival, and memory formation. As an immune-regulatory receptor, it primarily interacts with its ligand, OX40L (TNFSF4), which is expressed on antigen-presenting cells (APCs), such as dendritic cells, B cells, and macrophages. OX40’s role in immune modulation is significant because it amplifies T-cell responses during both acute infections and in chronic immune responses, such as autoimmune diseases and cancer. By sustaining T-cell activation and enhancing immune memory, OX40 has become a central target in immunotherapy research, especially in the contexts of cancer immunotherapy and autoimmune diseases. Its ability to promote prolonged immune responses also makes it a critical regulator in various immune-related diseases, where modulation of OX40-OX40L interactions can potentially benefit patient outcomes.

Related Products

APC-30057

APC Anti-Human CD134(Ber-ACT35)

Ver Producto
EH0310

Human TNFRSF4/OX40 (Tumor necrosis factor receptor superfamily member 4) ELISA Kit

Ver Producto
FITC-30057

FITC Anti-Human CD134(Ber-ACT35)

Ver Producto